BIO calls for approval of biotech salmon

05/1/2013 | BiofuelsDigest.com

BIO encouraged the FDA to approve AquaBounty Technologies' AquAdvantage biotech salmon, saying that all scientific steps required for regulatory approval have been completed. "This evaluation has been thorough. It is past time to provide a decision and let the market determine whether it supports this innovation that produces healthy food in a sustainable manner by using inland farms to help us meet global protein needs," said David Edwards, BIO's director of animal biotechnology.

View Full Article in:

BiofuelsDigest.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Director, Corporate Counsel
Regeneron
Tarrytown, NY